JENNIFER FOSTER: Open Payments
NPI 1083368641 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,534 in 55 payments from 12 companies in 2025. Trend: 2023 $630 · 2024 $662 · 2025 $1,534
Food & beverage: $1,534
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $300 |
| Insulet Corporation | 7 | $229 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $199 |
| Dexcom, Inc. | 3 | $161 |
| Sequel Med Tech, LLC | 2 | $160 |
| Tandem Diabetes Care, Inc. | 1 | $119 |
| Lilly USA, LLC | 7 | $114 |
| AstraZeneca Pharmaceuticals LP | 1 | $101 |
| Corcept Therapeutics | 4 | $83 |
| BETA BIONICS, INC. | 2 | $32 |
Products named: Ozempic, Omnipod, JARDIANCE, Dexcom G6 Transmitter, TWIIST, t:slim X2 Insulin Pump with Control-IQ, WAINUA, Korlym.
Industry payments across OH — which companies pay providers there.
